AGEN Agenus Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: AGEN

Price (delayed)

$7.825

Market cap

$325.85M

P/E Ratio

4.71

Dividend/share

N/A

EPS

$1.66

Enterprise value

$595.32M

?
Relative Growth: Rel. Growth: 82
Relative Strength: Rel. Strength: 97
Relative Valuation: Rel. Valuation: 97
Relative Profitability: Rel. Profitability: 72

Agenus is a leading immuno-oncology company targeting cancer with a comprehensive pipeline of immunological agents. The company was founded in 1994 with a mission to expand patient populations benefiting from ...

Highlights
The quick ratio has soared by 188% from the previous quarter and by 156% YoY
AGEN's net income has soared by 134% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://agenusbio.com
Peers: MRK JNJ CLDX BMY

Key stats

What are the main financial stats of AGEN

AGEN stock price

How has the Agenus stock price performed over time
Intraday
4.33%
1 week
27.65%
1 month
124.21%
1 year
45.99%
YTD
149.2%
QTD
155.72%

Financial performance

How have Agenus's revenue and profit performed over time
Revenue
$123.87M
Gross profit
$122.98M
Operating income
$7.81M
Net income
$64.61M
Gross margin
99.3%
Net margin
52.2%
AGEN's operating income has surged by 138% since the previous quarter and by 107% year-on-year
AGEN's operating margin has soared by 135% from the previous quarter and by 106% YoY
AGEN's net income has soared by 134% YoY
Agenus's net margin has surged by 127% YoY

Price vs fundamentals

How does AGEN's price correlate with its fundamentals

Growth

What is Agenus's growth rate over time

Valuation

What is Agenus stock price valuation
P/E
4.71
P/B
N/A
P/S
2.4
EV/EBIT
4.89
EV/EBITDA
4.61
EV/Sales
4.81
The EPS has surged by 119% year-on-year
AGEN's equity is up by 35% YoY and by 18% QoQ
The stock's price to sales (P/S) is 109% more than its last 4 quarters average of 1.1 but 12% less than its 5-year quarterly average of 2.6
Agenus's revenue has increased by 24% YoY and by 8% from the previous quarter

Efficiency

How efficient is Agenus business performance
Agenus's return on assets has surged by 139% YoY
The return on sales has surged by 103% since the previous quarter
Agenus's ROIC has increased by 30% from the previous quarter

Dividends

What is AGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AGEN.

Financial health

How did Agenus financials performed over time
AGEN's total assets is 55% lower than its total liabilities
The quick ratio has soared by 188% from the previous quarter and by 156% YoY
AGEN's total liabilities is down by 21% YoY and by 18% from the previous quarter
AGEN's equity is up by 35% YoY and by 18% QoQ
The debt to equity has declined by 12% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.